Biocon Biologics successfully integrates acquired biosimilars business across 120 countries
Express Pharma
DECEMBER 18, 2023
Over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of the biosimilars business acquired from Viatris. I congratulate and thank the entire Biocon Biologics team – colleagues, advisors, and partners.
91 
Let's personalize your content